Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 29.10.2024
Pharming Group NV
Company Name:
Pharming Group NV
ISIN:
NL0010391025
Reason for the research:
Q3/24 results
Recommendation:
Buy
from:
29.10.2024
Target price:
€1.70
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Simon Scholes
First Berlin Equity Research has published a research update on Pharming Group NV (ISIN: NL0010 [ … ]
Tue, 29.10.2024
ParTec AG
Press invitation for 6 November 2024:
ParTec AG hosts press conference on the background and effects of the patent infringement lawsuits against NVIDIA and Microsoft
Date: 6 November 2024
Time: 6 to 7.30 pm CET
Location: virtual via MS Teams meeting
The German ParTec AG and its licencee BF exaQC AG have filed a patent infringement lawsuit ag [ … ]
Tue, 29.10.2024
ZenaTech Inc.
TORONTO, Ontario – ZenaTech, Inc. (Nasdaq: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone solutions and enterprise SaaS (Software-as-a-Service) solutions, today announced it will establish a new company in Taiwan to manufacture drone sensors and components for use in the drone products produced by its su [ … ]
Tue, 29.10.2024
Goldinvest Consulting GmbH
Diapers are a highly competitive, global, still growing 85-billion-dollar business. This has been known at least since the meteoric rise (and fall) of what was probably the most famous diaper start-up of the past decades: www.diapers.com. In the early days of e-commerce, the company relied on direct sales, bypassing the middleman. We know how the s [ … ]
Tue, 29.10.2024
Pentixapharm Holding AG
Berlin and Würzburg, Germany, October 29, 2024 – The National Cancer Institute (NCI) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), two highly respected research organizations belonging to the US government's National Institutes of Health (NIH), have started a clinical trial involving 77 patients to see if Pentixa [ … ]
Tue, 29.10.2024
Haier Smart Home Co.,Ltd.
Haier Smart Home Releases Q3 2024 Report: Sustainable Growth in Domestic and International Markets through Innovative Smart Product Portfolio
Total Revenue of RMB 202.97 billion achieved (9M 2023: RMB 198.66 billion)
Net Profit attributable to the Parent Company grew by approx. 15.3% (Q3 2023: RMB 13.15 billion)
Further Focus on ESG with Haier´s [ … ]
Tue, 29.10.2024
Immunic AG
Immunic to Participate in Industry, Scientific and Investor Conferences in November
NEW YORK, October 29, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following indus [ … ]
Tue, 29.10.2024
Ningbo Information Office
EQS Newswire / 29/10/2024 / 11:14 CET/CEST
NINGBO, CHINA - Media OutReach Newswire - 29 October 2024 - The highly anticipated 9th Zhejiang Book Fair and the 2024 Maritime Silk Road Culture and Tourism Expo, also known as the 2024 Ningbo International Tourism Expo (referred to as the "Maritime Silk Road culture and tourism grand expo"), officia [ … ]
Tue, 29.10.2024
Linde plc
Linde Starts Up Supply of Industrial Gases to PT Freeport Indonesia
Woking, UK, October 29, 2024 – Linde (Nasdaq:LIN) announced it has started up the supply of industrial gases to PT Freeport Indonesia, a leading mining company in Indonesia and subsidiary of Freeport-McMoRan Inc.
Linde has invested $120 million to build, own and operate a new on- [ … ]
Tue, 29.10.2024
Knaus Tabbert AG
Company Name:
Knaus Tabbert AG
ISIN:
DE000A2YN504
Reason for the research:
Update
Recommendation:
Kaufen
from:
29.10.2024
Target price:
€54
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) verö [ … ]